A new kindred with asymptomatic hypobetalipoproteinemia is reported. The proband, age 67, differs from previously described cases in several respects: (a) unusually low levels of low density lipoprotein (LDL) cholesterol (4-8 mg/dl); (b) normal triglyceride levels; (c) low levels of high density lipoprotein; (d) mild fat malabsorption; and (e) a defect in chylomicron clearance. On a high-carbohydrate diet his plasma triglyceride levels, instead of rising, actually fell. Turnover of triglycerides in very low density lipoproteins (VLDL) was low (2.8 mg/kg per h). Fractional catabolic rate of LDL protein was just above the normal range (0.655/d) but net turnover was <10% of normal (0.65 mg/kg per d). The half-life of his chylomicrons was 29 min, five times the normal value. Postheparin lipoprotein lipase activity was normal and apolipoprotein C-II, the activator protein for lipoprotein lipase, was present and functional. Apolipoprotein C-III 1 , however, was not detected in the VLDL fraction, a finding previously reported in patients with abetalipoproteinemia. Fecal excretion of cholesterol was almost twice normal; total sterol balance was increased by @40%. The unusual features in the proband that distinguish him from previously described cases and from his affected first-degree relatives suggested that, in addition to the basic gene defect affecting LDL metabolism, he might have a second abnormality affecting clearance of chylomicrons and VLDL. 
INTRODUCTION
Extremely low levels of plasma ,8-lipoproteins are encountered in at least two distinct inherited disease states (1) . In "abetalipoproteinemia" no apoprotein B is detected in the plasma even by the most sensitive immunochemical assays. Ordinary methods fail to reveal low density lipoprotein (LDL),1 very low density lipoprotein (VLDL), or chylomicrons. By concentrating the fraction with d < 1.063 it is possible to demonstrate lipoproteins but these are abnormal in composition and structure, i.e., they do not represent normal LDL or VLDL (1) (2) (3) (4) . This apparently total deficiency of lipoproteins containing apoprotein B is associated with a severe clinical syndrome, usually apparent in infancy (5) . The syndrome is characterized by fat malabsorption, retinitis pigmentosa, neurologic involvement (including cerebellar ataxia and mental retardation), and acanthocytosis. The inheritance pattern is autosomal recessive, with parents having normal lipoprotein levels and none of the clinical manifestations.
In "hypobetalipoproteinemia" plasma LDL can be demonstrated but the levels are sharply reduced. This partial deficiency of LDL is not associated with the severe clinical manifestations characteristic of abetalipoproteinemia. Most patients are totally asymptomatic and the diagnosis is usually made by chance during a routine clinical work-up or in screening programs. Fat absorption is normal or only marginally impaired; acanthocytes are rarely seen; growth and development in infancy and childhood are almost always normal. A few patients have had neurological signs and symptoms but the other hypobetalipoproteinemic members of these kindreds were unaffected. The nature of the relationship between the neurologic changes and the hypobetalipoproteinemia remains unclear. This disorder is inherited in an autosomal dominant pattern.
Recently it has become clear that a double dose ofthe abnormal allele causing hypobetalipoproteinemia can produce a severe clinical picture not readily distinguishable from that of abetalipoproteinemia (6, 7) . However, the clearly dominant inheritance of hypobetalipoproteinemia in these kindreds indicates that homozygous hypobetalipoproteinemia represents a mutation distinct from that in abetalipoproteinemia.
In this paper we present the results of intensive studies in an asymptomatic man in his seventh decade with a familial hypobetalipoproteinemic syndrome different from those previously reported in a number of respects: (a) extremely low LDL levels (4) (5) (6) (7) (8) (11) .
Cholesterol balance studies were carried out according to methods previously described (12) (13) (14) . Stools were collected for the last 10 (15) and by polyacrylamide gel electrophoresis (16) . Quantitative mseasurements ofapolipoprotein levels in whole plasma and in ultracentrifugal fractions were carried out by radial immunodiffusion and by double-antibody radioimmunoassay using methods previously described (17, 18) . Isoelectric focusing for determinations of apolipoprotein (apo)E3/apoE2 ratios was done by the method of Wamick et al. (19) . Total protein in fractions was determined by the method of Lowry et al. (20) .
For measurement of LDL apoprotein turnover, LDL was prepared from the plasma ofa normal donor negative for hepatitis B antigen and with a history of repeated uneventful plasma donations in the past. The LDL fraction (d 1.019-1.063) was iodinated with 125I-Cl by a modification of the method of McFarlane (21) and Bilheimer et al. (22) . The plasma and its fractions were handled with sterile precautions, passed through a 0.45-,im Millipore filter (Millipore Corp., Bedford, Mass.), and then tested for bacterial contamination and pyrogenicity before use. The recipient was started on KI, 900 mg/d, just before study and maintained on that dosage throughout. The labeled LDL (50 ,uCi) was injected after an overnight fast. Blood samples were drawn at frequent intervals during the first 24 h and daily thereafter. Previous studies have shown that little or no 125I-LDL radioactivity is transferred to other lipoprotein fractions and analyses were based therefore on total radioactivity per milliliter of plasma. The plasma radioactivity decay curve was analyzed by the method of Matthews (23) for determination of fractional catabolic rate.
For 36 h before measurement of VLDL triglyceride turnover, fat was deleted from the patient's diet to eliminate possible ambiguities owing to chylomicronemia. Carbohydrate and protein intake were continued at the same level in frequent small feedings of liquid formula (24) . For determination of the turnover of VLDL triglycerides, ['4C]glycerol was injected intravenously and blood samples were taken at intervals for isolation of the VLDL fraction. Lipids were extracted from each sample using isopropanol and phospholipids were adsorbed onto silicic acid. After saponification, the nonsaponifiable lipids were extracted into heptane. Free glycerol was determined in one aliquot of the aqueous phase and radioactivity was assayed by liquid scintillation counting of a second aliquot. Turnover was determined using multicompartmental analysis as described by Zech et al. (25) .
Fibroblast cultures were initiated from a skin biopsy taken from the suprascapular region at the time of the first hospitalization. The cells were studied at the seventh passage. Methods for maintaining the cells in culture have been previously described (26) . LDL isolated from pooled normal human plasma was iodinated as described above and its surface binding, internalization, and degradation were determined in normal cultured fibroblasts and in the patient's fibroblasts. In addition, competition between LDL isolated from the patient and iodinated normal LDL was studied and compared with competition between unlabeled LDL from a normal donor and iodinated LDL prepared from pooled normal human plasma.
RESULTS
Plasma lipids and lipoproteins. Total plasma cholesterol and triglyceride values during three different dietary periods in the course of metabolic studies are The VLDL fraction contained only 0.9 mg/dl of apoB despite the relatively normal total triglyceride concentration in the VLDL fraction, i.e., the apoB content was abnormally low. The total protein in this fraction was 2.8 mg/dl, suggesting that apoB accounted for approximately one-third ofthe total protein, in good agreement with published values for normal VLDL (27) . As shown in Fig. 1 the VLDL fraction was relatively enriched in apoE ("arginine-rich protein"). The band running just behind apoE has not been further characterized. Isoelectric focusing on two occasions gave apoE3/apoE2 ratios of 0.96 to 0.90. Ratios below 1.0 are considered to be in the intermediate range found in subjects heterozygous for apoE3 deficiency (19) . It is also evident from Fig. 1 that there is a marked deficiency ofapoC-III, accompanied by a relative increase in apoC-III2. (18) . As shown in Fig. 1 , the pattern of apoproteins in HDL was normal. Properties and turnover of VLDL. On electron microscopy the VLDL fraction was not unusual except for the presence of some particles with diameters larger than those usually found in this fraction. The mean diameter was 375+127 A (SD). Kane This preparation of LDL was functionally compared with normal LDL by examining its interaction with the high affinity LDL receptor site on the membrane of normal human fibroblasts (29) . The binding, internalization, and degradation of 1251-labeled normal LDL was determined as previously described (26) in the presence or in the absence of added unlabeled LDL either from a normal subject or from H.J.B. As shown in Fig. 2 , the degradation of the labeled normal LDL was reduced -70% by unlabeled normal LDL and to the same extent by unlabeled LDL from H.J.B. The same was true with respect to binding and internalization (data not shown).
We considered the possibility that H.J.B. might be degrading LDL at an abnormally high rate and studied his own skin fibroblasts in culture from this point of view. Degradation of LDL (10 gg/ml) by the patient's cells grown in 10% fetal calf serum and incubated for 24 h in lipoprotein-deficient serum for 24 h was slightly less than that seen in a normal fibroblast line. We also tested whether the patient's cells would show the normal suppression of LDL receptor number in response to LDL in the medium (29) . After a 24-h exposure to LDL (50 ,g/ml), degradation rate decreased by 79% in H.J.B. cells and by 76% in control fibroblasts (Fig. 3) . The cells were incubated with normal 125I-LDL (10 j,g/ml) for 3 h, either after a 24-h incubation in lipoprotein-deficient medium or after an additional 24-h incubation with normal LDL (50 jig/ml). The latter was removed by washing the monolayer before addition of 1251-LDL and degradation was measured as previously described.
Turnover of LDL was determined using 125I-LDL prepared from the plasma of a normal donor. The timecourse ofdisappearance of 1251 from the plasma is shown in Fig. 4 (33) .
The apparent chylomicron clearance defect and the low fractional catabolic rate for VLDL triglycerides suggested the possibility of a lipoprotein lipase deficiency. However, both postheparin lipoprotein lipase and hepatic triglyceride lipase, although below the mean normal levels, were found to be within normal limits (10 and 15 ,ueq FFA/ml per h, respectively, vs.
normal ranges of 8-50 and 3-100) (34) . ApoC-II was present (Fig. 1) and the patient's plasma was able to activate lipoprotein lipase in postheparin plasma of a normal subject.
Sterol balance. If endogenous cholesterol biosynthesis by peripheral tissues is normally suppressed by LDL, it should be abnormally high in H.J.B. As shown in Table IV , neutral steroid excretion on a low intake of dietary cholesterol was almost twice normal. Acidic steroid excretion, however, was somewhat below normal so that net cholesterol balance was increased-40%.
Family study. The proband's mother, age 92, is well except for mild diabetes. She had 12 siblings, 2 ofwhom Table V . The proband's mother has hypobetalipoproteinemia (LDL cholesterol 46 mg/dl) but much less striking than that of H.J.B. Lipoprotein quantification has been carried out on all living siblings (one sister died in her 20s of rheumatic heart disease) and both children of the proband. One brother (A.L.B.) and one sister (J.Y.G.) have hypobetalipoproteinemia as striking as that in H.J.B. -LDL cholesterols of 4 and 5 mg/dl, respectively. Both differ, however, in having low plasma triglyceride levels and normal HDL levels. Neither showed fasting chylomicronemia. Three additional siblings (J.L.P., R.W.B., and B.R.V.) have LDL cholesterol levels below 100 mg/dl and total plasma triglycerides below 40 . The remaining three siblings have LDL cholesterol levels in the low normal range and normal total plasma triglyceride levels.
Both daughters have hypobetalipoproteinemia (LDL cholesterol levels 29 and 40 mg/dl). They also have low triglyceride levels (31 and 21 mg/dl) and normal to high HDL cholesterol levels (67 and 51 mg/dl). Thus the proband differs from all of the other affected members of the kindred in having chylomicronemia, normal plasma triglyceride levels, and low HDL levels.
None of the members of the kindred gave histories of abnormal childhood development, steatorrhea, visual disturbances, or neurologic symptoms. [37] ). An absence of carbohydrate induction might be expected if our patient's capacity to secrete apoB is already fully expressed. However, he actually showed a decrease in plasma triglyceride levels on the fat-free diet, suggesting the possibility that a significant part ofhis VLDL may have its origin from chylomicrons.
The ability of LDL to regulate cholesterol biosynthesis (at the hydroxymethylglutaryl-CoA reductase step) in cultured cells of animal and human origin is well established (42) . There is evidence from animal studies indicatinig that this suppression is operative in vivo (43, 44) but it is not known with certainty whether or not synthesis in peripheral tissues in man is normally suppressed by LDL. Total sterol output in patients with abetalipoproteinemia is increased (45) but much or all of the increase might be due to increased hepatic synthesis due to the accompanying malabsorption and failure to make chylomicrons. The patient described here presented the unusual combination of normal (or nearly normal) fat absorption and chylomicron formation but almost total absence of LDL. If the relationship between intravascular and extravascular LDL concentrations in H.J.B. is similar to that in normal and hyperlipidemic subjects (46) , his extravascular LDL cholesterol levels would be _0.5 mg/dl or 5 ,ug/dl, i.e., below the level needed to saturate the high affinity receptors (42) . The finding of a 40% increase in total sterol output is compatible with the conclusion that cholesterol synthesis is normally suppressed by LDL. Because of the wide range of normal values, however, a firm conclusion will require additional studies of patients of this kind.
Hypobetalipoproteinemia (LDL cholesterol concentration >2 SD below the normal) was present in six 298 Steinberg, Grundy, Mok, Turner, Weinstein, Brown, and Albers siblings (including the proband) of the nine examined: three males and three females were affected. The proband's mother and both of his children were also affected. The findings are compatible with autosomal dominant inheritance. Three of the affected siblings had LDL cholesterol levels below 10 mgldl whereas the other three had levels ranging from 62 to 83 mg/dl. In the absence of other information one would have to seriously consider the possibility that H.J.B. and his siblings, J.Y.G., and A.L.B., are actually homozygotes (i.e., have a double dose ofa dominant allelic mutation) whereas his mother, the other three siblings and his daughters are heterozygotes. However, in previously described kindreds the homozygotes have been characterized by an absence of detectable LDL and by the signs and symptoms of abetalipoproteinemia in early childhood (5) (6) (7) . Only if the mutation in the H.J.B. kindred is distinct from that in the previously described kindreds does the suggestion of homozygosity have weight. H.J.B. differs both from the other affected members of his kindred and from most previously described hypobetalipoproteinemic patients in that his triglyceride levels are normal and he displays fasting chylomicronemia on many occasions. In view of his demonstrated defect in chylomicron clearance and in the absence of any obvious environmental factors, we considered the possibility ofan abnormality in apoC-II (47) but found none. The low apoE3/apoE2 ratio in his VLDL may be relevant to his clearing defect. Utermann and co-workers have shown that patients with familial dysbetalipoproteinemia, associated with accumulation of chylomicron "remnants", have complete or nearly complete apoE3 deficiency (48) . Interestingly, some subjects with the complete deficiency ofapoE3 do not have hyperlipoproteinemia although their plasma shows the characteristic abnormal "floating" betalipoprotein (49) . These patients have abnormally low plasma LDL levels. Intermediate degrees of apoE3 deficiency (heterozygous state) are extremely common (49, 50) but are not necessarily associated with hyperlipoproteinemia. It is possible that the low apoE3/apoE2 ratio in our patients accounts for some of the unusual features in his case. A deficiency of apoC-III1 has been reported in abetalipoproteinemia (4, 51) but this is the first reported example in apoC-III, deficiency in hypobetalipoproteinemia. Whether it represents a primary defect or a secondary consequence of low LDL levels is not known.
The nature of the mutant allele in hypobetalipoproteinemia remains unknown. The present studies and those in two other kindreds (38, 39) show that it leads to a marked reduction in the rate of apoB production but how this is effected is not known. Malloy and Kane recently described a child with hypobetalipoproteinemia and normal triglyceride levels (52) . The clinical syndrome in this case differs in a number of respects from that of the present case and the apoB appears to be structurally abnormal. Structural abnormalities in the LDL have not been demonstrated in our case or other cases but further efforts are in order to look for subtle abnormalities. It is equally possible that any one of the many steps in VLDL biosynthesis, packaging or secretion may be involved in a regulatory sense. This might help account for the observed variability in expression.
